Linezolid was effective in the treatment of a case of multidrug-resistant tuberculotic spondylitis

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1495, 2005-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment and Prevention of Multidrug-Resistant Tuberculosis

By Bastian I. Colebunders R.

Drugs, Vol. 58, Iss. 4, 1999-10 ,pp. : 633-661

Adis International

Access to resources Recommend Favorite

Treatment Options for Multidrug-Resistant Acinetobacter Species

By Gilad Jacob

Drugs, Vol. 68, Iss. 2, 2008-01 ,pp. : 165-189

Adis International

Access to resources Recommend Favorite

Antivirals/immunosuppressants: Multidrug-resistant cytomegalovirus: case report

Reactions Weekly, Vol. 1, Iss. 1408, 2012-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Comparison of the Pharmacokinetics of Two Dosage Regimens of Linezolid in Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis Patients

By Alffenaar Jan-Willem C.

Clinical Pharmacokinetics, Vol. 49, Iss. 8, 2010-08 ,pp. : 559-565

Adis International

Access to resources Recommend Favorite

A Systematic Review of the Cost and Cost Effectiveness of Treatment for Multidrug-Resistant Tuberculosis

By Fitzpatrick Christopher Floyd Katherine

PharmacoEconomics, Vol. 30, Iss. 1, 2012-01 ,pp. : 63-80

Adis International

Access to resources Recommend Favorite